We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.65%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$418M
AUM Growth
-$30.8M
(-6.9%)
Cap. Flow
-$37.5M
Cap. Flow
% of AUM
-8.97%
Top 10 Holdings %
Top 10 Hldgs %
54.35%
Holding
163
New
44
Increased
31
Reduced
48
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$3.75M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$3.59M |
| 3 |
Teck Resources
TECK
|
+$3.58M |
| 4 |
Popular Inc
BPOP
|
+$3.3M |
| 5 |
GTS
Triple-S Management Corporation
GTS
|
+$3.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molson Coors Class B
TAP
|
+$3.57M |
| 2 |
UGI
UGI
|
+$3.26M |
| 3 |
Universal Health Services
UHS
|
+$3.1M |
| 4 |
Wells Fargo
WFC
|
+$3.08M |
| 5 |
Concrete Pumping Holdings
BBCP
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.06% |
| 2 | Industrials | 7.6% |
| 3 | Materials | 7.59% |
| 4 | Consumer Discretionary | 5.8% |
| 5 | Healthcare | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bioceres Crop Solutions
BIOX
$22M
| – | – |
-19,121
| Closed | -$195K |
|
127
Caleres
CAL
$487M
| – | – |
-47,807
| Closed | -$1.04M |
|
128
Costamare
CMRE
$1.77B
| – | – |
-90,625
| Closed | -$871K |
|
129
Cisco
CSCO
$479B
| – | – |
-20,328
| Closed | -$1.05M |
|
130
Cemex
CX
$16.3B
| – | – |
-117,805
| Closed | -$821K |
|
131
Crane NXT
CXT
$3.07B
| – | – |
-25,151
| Closed | -$821K |
|
132
EQT Corp
EQT
$32.3B
| – | – |
-9,486
| Closed | -$177K |
|
133
Diamondback Energy
FANG
$52.7B
| – | – |
-14,091
| Closed | -$1.03M |
|
134
Genesco
GCO
$422M
| – | – |
-30,614
| Closed | -$1.45M |
|
135
Genuine Parts
GPC
$18.7B
| – | – |
-20,426
| Closed | -$2.36M |
|
136
Ituran Location and Control
ITRN
$1.05B
| – | – |
-38,791
| Closed | -$824K |
|
137
CALL
Lumen
LUMN
$6.44B
| – | – |
-91,100
| Closed | -$1.22M |
|
138
PUT
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
| – | – |
-86,000
| Closed | -$13.8M |
|
139
PUT
iShares S&P 100 ETF
OEF
$20.5B
| – | – |
-626,200
| Closed | -$153M |
|
140
O-I Glass
OI
$1.08B
| – | – |
-25,703
| Closed | -$379K |
|
141
Oracle
ORCL
$423B
| – | – |
-17,845
| Closed | -$1.25M |
|
142
Sally Beauty Holdings
SBH
$1.58B
| – | – |
-83,126
| Closed | -$1.67M |
|
143
Silgan Holdings
SLGN
$4.41B
| – | – |
-10,410
| Closed | -$437K |
|
|
STR
144
DELISTED
Sitio Royalties
STR
| – | – |
-3,532
| Closed | -$64K |
|
145
AT&T
T
$163B
| – | – |
-69,627
| Closed | -$1.59M |
|
146
Telephone and Data Systems
TDS
$3.75B
| – | – |
-22,601
| Closed | -$519K |
|
147
Tecnoglass Holdings Inc.
TGLS
$1.96B
| – | – |
-92,289
| Closed | -$1.11M |
|
|
148
UGI
UGI
$7.33B
| – | – |
-79,553
| Closed | -$3.26M |
|
|
149
Universal Health Services
UHS
$10.5B
| – | – |
-23,268
| Closed | -$3.1M |
|
|
AD
150
Array Digital Infrastructure
AD
$3.05B
| – | – |
-34,693
| Closed | -$1.26M |
|
Similar funds
SIG
CAG
ORCP
ET
GC
MIAS
TAL
IIP
Invenomic Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Invenomic Capital Management held 163 positions worth $418M, down 6.9% from $448M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Invenomic Capital Management withdrew a net $37.5M in Q2 2021, closing 39 positions and reducing 48 holdings. Its most notable exit was UGI, an estimated $3.26M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9.1% of assets, up from 6.9% a quarter earlier, followed by Industrials and Materials.
Against the trend, Invenomic Capital Management opened a new position in Popular Inc worth $3.23M.
- Invenomic Capital Management's largest Q2 2021 buy was Popular Inc: 43,078 shares worth $3.23M.
- Invenomic Capital Management added most to Surgalign Holdings, Inc. Common Stock in Q2 2021, an estimated $3.75M increase.
- Invenomic Capital Management's biggest Q2 2021 reduction was Molson Coors Class B, cutting an estimated $3.57M.
- Invenomic Capital Management fully exited UGI in Q2 2021, selling an estimated $3.26M.
- Invenomic Capital Management's ten largest holdings make up 54% of its $418M portfolio in Q2 2021.
- Invenomic Capital Management opened 44 new positions and closed 39 in Q2 2021.
- Invenomic Capital Management's portfolio value fell 6.9% quarter-over-quarter to $418M.
Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.